Patrick J. Egan


Patrick J. Egan concentrates his practice in the areas of capital markets, securities, and corporate law. Patrick represents issuers, underwriters, and placement agents in a broad range of public and private securities transactions, including:

  • Initial public offerings (“IPOs”) and follow-on public offerings
  • At-the-market offerings (“ATMs”)
  • Uplistings
  • PIPEs and registered direct offerings (“RDOs”)
  • Private placements
  • Regulation D, Rule 144A, and Regulation S offerings
  • Registered "shelf" offerings
  • Rights offerings
  • Exchange offers

These transactions involve a variety of products, including common and preferred equity securities, equity-linked securities, high-yield debt, investment grade debt, and convertible debt. Patrick also regularly advises a variety of public companies in connection with SEC reporting and disclosure obligations and corporate law and governance matters, including compliance with Nasdaq and NYSE rules and regulations.

He began his career as a corporate and securities attorney in the New York office of an international Am Law 100 firm, and then continued as in-house counsel at a leading global financial services firm where he advised on matters related to investment banking, capital markets transactions, mergers and acquisitions, joint ventures, private equity investments, secured financing transactions, and other general corporate and securities matters.

During law school, he served as a member of the St. John’s Law Review.


  • Counsel to underwriters, placement agents, dealer managers, and agents in connection with numerous IPOs, follow-on offerings, including common stock and preferred stock offerings, at-the-market (“ATM”) offerings, and registered direct offerings.
  • Advise on follow-on public offerings, ATMs, equity lines, and registered direct offerings for companies engaged in life sciences, gaming, technology, residential and commercial construction, clothing design, and real estate.
  • Counsel to a Nasdaq-listed developer of oncology product candidates, involving:
    • $21 million registered direct offering
    • $10 million PIPE
    • $60 million ATM
  • Counsel to NYSE American-listed company, with $70 million raised off its ATM.
  • Counsel to a Nasdaq-listed developer of oncology product candidates, with more than $100 million raised off its ATM.
  • Counsel on IPOs of life sciences companies and companies engaged in boat manufacturing and shipping.
  • Counsel to a private issuer engaged in the life sciences industry in a $20 million Series A Preferred Stock round and a $125 million Series B Preferred Stock round.
  • Counsel to a private manufacturer of energy drinks in a $16 million convertible note purchase financing.
  • Counsel to a private company in the gene therapy field in connection with a $21 million Series A financing round.
  • Counsel to NYSE American-listed company acquisition of a company engaged in research and development with upfront payments and CVRs valued at approximately $70 million.
  • Counsel on uplistings of various OTC companies.
  • Advise on a $37 million rights offering for a REIT.
  • Advise on a $20 million private sale of a company involved in the trucking business.
  • Counsel to a New York-based global financial services firm listed on Nasdaq, in connection with its $160 million follow-on public equity offering and Rule 144A offering of $160 million of 4.50% convertible senior notes.
  • Counsel to a privately held, New York-based global financial services firm in connection with the issuance of $500 million of 7.875% senior unsecured notes in a Rule 144A offering. 
  • Counsel to a New York-based global media company in connection with the private placement of $250 million of 14.053% senior unsecured notes and detachable warrants.
  • Counsel global private equity firms in connection with the issuance of over four billion dollars of high-yield notes in Rule 144A/Regulation S offerings to partially finance LBOs.
  • Advise various micro-cap and mid-cap Nasdaq- and NYSE-listed companies in connection with securities law and general corporate and corporate governance matters, including the preparation of registration statements, annual reports, quarterly reports, current reports on Form 8-K, proxy statements, annual meetings, and Section 16 filings. Also report compliance under the Exchange Act and Nasdaq and NYSE listing standards.



  • New York


  • St. John's University School of Law, JD, cum laude
  • Boston College, BA, cum laude